Controlled comparison of buspirone and clomipramine in obsessive- compulsive disorder
- 1 January 1991
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 148 (1) , 127-129
- https://doi.org/10.1176/ajp.148.1.127
Abstract
Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study. Both drugs led to statistically significant and similar improvements in scores on the Yale-Brown Obsessive-Compulsive Rating Scale and other obsessive-compulsive and depression scales. This preliminary result warrants further exploration with a larger sample and other serotonergic agents.Keywords
This publication has 7 references indexed in Scilit:
- Buspirone augmentation of fluoxetine in obsessive-compulsive disorderAmerican Journal of Psychiatry, 1990
- Treatment of Obsessive-Compulsive Disorder With Clomipramine and Desipramine in Children and AdolescentsArchives of General Psychiatry, 1989
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989
- Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patientsAmerican Journal of Psychiatry, 1989
- Serotonergic Anxiolytics and Treatment of DepressionPsychopathology, 1989
- Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorderAmerican Journal of Psychiatry, 1988
- Drs. Jenike and Baer ReplyAmerican Journal of Psychiatry, 1988